Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 170

1.

Off-label use of atypical antipsychotics: cause for concern?

McKean A, Monasterio E.

CNS Drugs. 2012 May 1;26(5):383-90. doi: 10.2165/11632030-000000000-00000.

PMID:
22448598
2.

Summary of the comparative effectiveness review on off-label use of atypical antipsychotics.

Maher AR, Theodore G.

J Manag Care Pharm. 2012 Jun;18(5 Suppl B):S1-20. Review.

PMID:
22784311
3.

Indications of atypical antipsychotics in the elderly.

McKean A, Monasterio E.

Expert Rev Clin Pharmacol. 2015 Jan;8(1):5-7. doi: 10.1586/17512433.2015.974557. Epub 2014 Oct 29.

PMID:
25354148
4.

Comparative treatment patterns, resource utilization, and costs in stimulant-treated children with ADHD who require subsequent pharmacotherapy with atypical antipsychotics versus non-antipsychotics.

Sikirica V, Pliszka SR, Betts KA, Hodgkins P, Samuelson T, Xie J, Erder H, Dammerman R, Robertson B, Wu EQ.

J Manag Care Pharm. 2012 Nov-Dec;18(9):676-89.

5.

Increasing off-label use of antipsychotic medications in the United States, 1995-2008.

Alexander GC, Gallagher SA, Mascola A, Moloney RM, Stafford RS.

Pharmacoepidemiol Drug Saf. 2011 Feb;20(2):177-84. doi: 10.1002/pds.2082. Epub 2011 Jan 6.

6.

Off-label use of atypical antipsychotic medications in Canterbury, New Zealand.

Monasterio E, McKean A.

N Z Med J. 2011 Jun 10;124(1336):24-9.

PMID:
21946741
7.

Impact of FDA Black Box Warning on Psychotropic Drug Use in Noninstitutionalized Elderly Patients Diagnosed With Dementia: A Retrospective Study.

Singh RR, Nayak R.

J Pharm Pract. 2016 Oct;29(5):495-502. doi: 10.1177/0897190015579451. Epub 2015 Apr 27.

PMID:
25917167
8.

Questionable antipsychotic prescribing remains common, despite serious risks.

Kuehn BM.

JAMA. 2010 Apr 28;303(16):1582-4. doi: 10.1001/jama.2010.453. No abstract available.

PMID:
20424239
9.
10.

Analysis of the Appropriateness of Off-Label Antipsychotic Use for Mental Health Indications in a Veteran Population.

Painter JT, Owen R, Henderson KL, Bauer MS, Mittal D, Hudson TJ.

Pharmacotherapy. 2017 Apr;37(4):438-446. doi: 10.1002/phar.1910. Epub 2017 Mar 21.

PMID:
28164355
11.

Restrictions on pharmaceutical detailing reduced off-label prescribing of antidepressants and antipsychotics in children.

Larkin I, Ang D, Avorn J, Kesselheim AS.

Health Aff (Millwood). 2014 Jun;33(6):1014-23. doi: 10.1377/hlthaff.2013.0939.

12.

Off-Label Prescribing of Antipsychotics in Adults, Children and Elderly Individuals: A Systematic Review of Recent Prescription Trends.

Carton L, Cottencin O, Lapeyre-Mestre M, Geoffroy PA, Favre J, Simon N, Bordet R, Rolland B.

Curr Pharm Des. 2015;21(23):3280-97. Review.

PMID:
26088115
13.

Utilisation of extended release quetiapine (Seroquel XL™): Results from an observational cohort study in England.

Osborne V, Davies M, Layton D, Shakir SAW.

Eur Psychiatry. 2016 Mar;33:61-67. doi: 10.1016/j.eurpsy.2015.12.004. Epub 2016 Feb 10.

PMID:
26872067
14.

Regulating off-label promotion of medications: has the pendulum swung too far?

Hoffman MB, Yentzer BA, Feldman SR.

Skin Therapy Lett. 2015 May-Jun;20(3):1-4.

15.

Off-label use of second-generation antipsychotic agents among elderly nursing home residents.

Kamble P, Sherer J, Chen H, Aparasu R.

Psychiatr Serv. 2010 Feb;61(2):130-6. doi: 10.1176/ps.2010.61.2.130.

PMID:
20123817
16.

Diagnoses associated with use of atypical antipsychotics in a commercial health plan: a claims database analysis.

Citrome L, Kalsekar I, Guo Z, Laubmeier K, Hebden T.

Clin Ther. 2013 Dec;35(12):1867-75. doi: 10.1016/j.clinthera.2013.09.006. Epub 2013 Oct 8.

17.

Impact of FDA black box advisory on antipsychotic medication use.

Dorsey ER, Rabbani A, Gallagher SA, Conti RM, Alexander GC.

Arch Intern Med. 2010 Jan 11;170(1):96-103. doi: 10.1001/archinternmed.2009.456.

18.

[Early achievements of the Danish pharmaceutical industry--8. Lundbeck].

Grevsen JV, Kirkegaard H, Kruse E, Kruse PR.

Theriaca. 2016;(43):9-61. Danish.

PMID:
27491172
19.

Off-label second generation antipsychotics for impulse regulation disorders: a review.

Scheltema Beduin A, de Haan L.

Psychopharmacol Bull. 2010;43(3):45-81. Review.

PMID:
21150846
20.

Misuse and Associated Harms of Quetiapine and Other Atypical Antipsychotics.

Montebello ME, Brett J.

Curr Top Behav Neurosci. 2017;34:125-139. doi: 10.1007/7854_2015_424.

PMID:
26695164

Supplemental Content

Support Center